Shobha Mahtani Email Address

Assistant to Chairman and Chief Executive Officer

Omeros is a biopharmaceutical company committed to discovering, developing and commercializing both small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies and disorders of the central nervous system. Part of its proprietary PharmacoSurgery platform, the company's first drug product, OMIDRIA (phenylephrine and ketorolac injection) 1% / 0.3%, was broadly launched in the U.S. in April 2015. OMIDRIA is the first and only FDA-approved drug (1) for use during cataract surgery or intraocular lens (IOL) replacement to maintain pupil size by preventing intraoperative miosis (pupil constriction) and to reduce postoperative ocular pain and (2) that contains an NSAID for intraocular use. In the European Union, the European Commission has approved OMIDRIA for use in cataract surgery and lens replacement procedures to maintain mydriasis (pupil dilation), prevent miosis (pupil constriction), and to reduce postoperative eye pain. Omeros has clinical-stage development programs focused on: complement-associated thrombotic microangiopathies| complement-mediated glomerulonephropathies| Huntington's disease and cognitive impairment| and addictive and compulsive disorders. In addition, Omeros has a proprietary G protein-coupled receptor (GPCR) platform, which is making available an unprecedented number of new GPCR drug targets and corresponding compounds to the pharmaceutical industry for drug development, and a platform used to generate antibodies.

I am accustomed to providing in-depth, high-level professional and personal assistance to Chairmen & CEOs, who have also served as members of the White House Judiciary Committee; Chairman of the Federal Reserve Bank of San Francisco; and Deputy President of the International Federation of Accountants. I bring extensive experience working with Boards and business leaders in diverse environments (public company, not-for-profit and for-profit corporations). I enjoy a fast paced environment, and a challenge to meeting the highest expectations of my employers. Being proactive, creative and attentive are essential factors to accomplishing tasks with little or no guidance. • Comfortable in the International arena •Strong communication skills; both one-on-one and in groups •Take initiative and work productively •Solve problems and provide solutions